Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Restoring Confidence Should Be FDA Commissioner’s Top Priority – Nissen

This article was originally published in The Tan Sheet

Executive Summary

The next FDA commissioner must restore waning faith in the agency, which is enduring a "crisis of confidence," according to cardiologist and drug researcher Steven Nissen

You may also be interested in...



FDA Commissioner Search Should Adopt Team Approach – Stakeholders

The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say

FDA Commissioner Search Should Adopt Team Approach – Stakeholders

The Obama administration's search for FDA's next leader should center on finding a team of qualified people - rather than just a single commissioner - to head the agency, former FDA officials and industry executives say

Researcher In Plan B Survey Supports Removing Age Restriction

The safety record of emergency contraceptive Plan B supports removing age restrictions on sales of the product, according to Rebekah E. Gee, the lead researcher behind a survey on access to the drug and an advocate for women's access to reproductive medicine

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS102418

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel